Clinical trials
Completed Tetanus trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
249 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 1 |
| 2002 | 5 |
| 2003 | 14 |
| 2004 | 9 |
| 2005 | 14 |
| 2006 | 33 |
| 2007 | 16 |
| 2008 | 15 |
| 2009 | 10 |
| 2010 | 14 |
| 2011 | 21 |
| 2012 | 12 |
| 2013 | 11 |
| 2014 | 8 |
| 2015 | 6 |
| 2016 | 8 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 249 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 97 |
| Sanofi Pasteur, a Sanofi Company | 56 |
| Sanofi | 18 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 9 |
| Merck Sharp & Dohme LLC | 6 |
| CanSino Biologics Inc. | 5 |
| Crucell Holland BV | 3 |
| Novartis Vaccines | 3 |
| Oxford University Clinical Research Unit, Vietnam | 3 |
| Zhuhai Trinomab Pharmaceutical Co., Ltd. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tetanus | 249 |
| Diphtheria | 208 |
| Whooping Cough | 141 |
| Poliomyelitis | 99 |
| Haemophilus Infections | 92 |
| Hepatitis B | 91 |
| Meningococcal Infections | 8 |
| Virus Diseases | 7 |
| Influenza, Human | 6 |
| Measles | 6 |
Trials
Showing 1 to 25 of 249. Each trial links to its page on Pharma Observatory.
149 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.